ARQ vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

ARQ

33.1
AI Score
VS
ASTH Wins

ASTH

45.3
AI Score

Investment Advisor Scores

ARQ

33score
Recommendation
SELL

ASTH

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ARQ ASTH Winner
Revenue 3.90M 2.96B ASTH
Net Income 7.66M 47.13M ASTH
Net Margin 196.5% 1.6% ARQ
Operating Income -1.71M 102.73M ASTH
ROE 9.9% 5.5% ARQ
ROA 9.2% 2.0% ARQ
Total Assets 82.84M 2.34B ASTH
Cash 34.76M 396.23M ASTH
Current Ratio 7.81 1.25 ARQ

Relative Price Performance (Last 90 Days)

ARQ 1M: +54.9% · 3M: +27.8% ASTH 1M: -17.0% · 3M: -23.3%

Current Technical Phase

ARQ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 78

RSI (14): 78.0 · Price: $2.99

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $31.32

Fundamentals Snapshot

Metric ARQ ASTH
Market Cap — —
Forward P/E -44.6 9.5
Trailing P/E — 31.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.1%
Operating Margin 0.1% 0.0%
EPS -1.20 1.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.